NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

Pegfilgrastim, Quantity: 6 mg

Disponível em:

Accord Healthcare Pty Ltd

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Via de administração:

Subcutaneous

Unidades em pacote:

1 prefilled syringe

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Resumo do produto:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Registered

Data de autorização:

2019-08-19